US3420233A - Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region - Google Patents
Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region Download PDFInfo
- Publication number
- US3420233A US3420233A US510161A US3420233DA US3420233A US 3420233 A US3420233 A US 3420233A US 510161 A US510161 A US 510161A US 3420233D A US3420233D A US 3420233DA US 3420233 A US3420233 A US 3420233A
- Authority
- US
- United States
- Prior art keywords
- ulcers
- epithelialization
- gold leaf
- ulcer
- granulation tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010063560 Excessive granulation tissue Diseases 0.000 title description 8
- 210000001126 granulation tissue Anatomy 0.000 title description 8
- 238000000034 method Methods 0.000 title description 8
- 230000002792 vascular Effects 0.000 title description 6
- 238000004519 manufacturing process Methods 0.000 title description 5
- 230000004936 stimulating effect Effects 0.000 title description 4
- 230000001225 therapeutic effect Effects 0.000 title description 3
- 208000025865 Ulcer Diseases 0.000 description 38
- 231100000397 ulcer Toxicity 0.000 description 37
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000003902 lesion Effects 0.000 description 10
- 230000035876 healing Effects 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- 206010056340 Diabetic ulcer Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- 208000000979 Erythema Induratum Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000006123 Myiasis Diseases 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044546 Traumatic ulcer Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 230000037446 allergic sensitization Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000010953 base metal Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007654 ischemic lesion Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Definitions
- ABSTRACT OF THE DISCLOSURE A method of treating a cutaneous ulcer by the application of porous gold leaf, establishing an electrostatic difierential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying the porous gold leaf thereto.
- This invention relates to the treatment of ischemic ion-healing ulcers of the skin by the application of gold leaf.
- the Gold leaf as used herein, means 23K XX Deep Gold Leaf for Glass, which is a standard designation for the partcular type of gold leaf used in this method and which type, supplied by the Hastings Company, of Philadelphia, Pcnnslyvania, can be obtained at artist supply stores. Its thickness is about 0.0000036 inch.
- This gold leaf is characterized by low content of base metal, a certain porosity, a thickness to permit easy handling and manual application over a skin ulcer so that it closely conforms to virtually all the minute and varied contours of the ulcer and the immediate surrounding area. Substantially thinner gold leaf is difficult to handle because it tends to adhere to the interleaving paper tissues with which it is packaged. Substantially thicker gold leaf does not accommodate to the irregular surface of an ulcer and tends to be too occlusive.
- the gold leaf remained in situ except in the case of one incontinent Woman with a decubitus ulcer of the buttock (the washing away of the gold by urine every nite necessitate daily reapplication), The sites Were observed and the gold leaf was re-applied at two day intervals.
- the patients were random, constituting all the available patients with non-healing ulcers at the institution in which the study was performed. A compilation of the study is as follows:
- Non-healing cutaneous ulcers means those which do not respond to usual active therapy.
- Usual active therapy means topical applications of antibiotic and proteolytic agents (including aloe vera).
- Granulation as used herein, means tissue which includes blood vessels.
- the application of gold leaf on to ulcers results in stimulation of vascular activity and the production of granulation tissue.
- the porosity of the gold leaf permits some evaporation of the moisture beneath it, it having been observed that if the leaf is covered by an occlusive substance or dressing, there is interference with healing.
- the gold leaf can be applied Without initially swabbing of the site, it is preferred that the site first be swabbed with ethyl alcohol, not only to cleanse it, but also to establish the electrostatic differential which causes the leaf to adhere closely to the irregular surface of the ulcer with little or no further manipulation required.
- the invention embraces a therapeutic device, i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin.
- a therapeutic device i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin.
- the invention is not limited to the specific method or article, but is intended to cover all substitutions, modifications, and equivalents within the scope of the following claim.
- the method of stimulating epithelialization in a cutaneous region at and proximate to an avascular ulcer other than a cutaneous region fed by blood containing sickle cells by means of sterile porous gold leaf applied thereto which comprises, first establishing an electrostatic differential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying said sterile porous golf leaf in intimate engagement over said ulcer and the cutaneous surface immediately contiguous thereto, and maintaining said gold leaf so applied until epithelialization is stimulated and develops at the ulcer.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
United States Patent Ofifice 3,420,233 Patented Jan. 7, 1969 3,420,233 METHOD AND THERAPEUTIC DEVICE FOR STIMULATING VASCULAR ACTIVITY, PRO- DUCTION F GRANULATION TISSUE, AND EPITHELIALIZATION IN A CUTANEOUS REGION Naomi M. Kanof, 2120 Bancroft Place NW., Washington, D.C. 20008 No Drawing. Filed Nov. 24, 1965, Ser. No. 510,161 US. Cl. 128-260 1 Claim Int. Cl. A61m 35/00 ABSTRACT OF THE DISCLOSURE A method of treating a cutaneous ulcer by the application of porous gold leaf, establishing an electrostatic difierential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying the porous gold leaf thereto.
This invention relates to the treatment of ischemic ion-healing ulcers of the skin by the application of gold leaf.
In previous reports (Gallager, I. P., and Geschickter, C. F.: The Use of Charged Gold Leaf in Surgery, JAMA, 189:928, 1964, and Editorial Comment, JAMA, 189:944, 1964) investigations into the use of gold leaf in patching the dura mater was disclosed. The subject arose out of observations of the combination of the metals characteristics of adhesion and to the extreme pliability to minute topographic variations of body tissues, plus its well-known absence of allergic sensitization, of irradiation, and of oxidation. Pilot experiments in which 68 non-healing electrodesiccated cutaneous ulcer sites were dressed with electrostatic gold leaf tended to confirm the original hypothesis that, by the application of gold leaf over cutaneous ulcers, early restitution of tissue could be seen to be taking place. Clinically, it soon became apparent that the Gold leaf, as used herein, means 23K XX Deep Gold Leaf for Glass, which is a standard designation for the partcular type of gold leaf used in this method and which type, supplied by the Hastings Company, of Philadelphia, Pcnnslyvania, can be obtained at artist supply stores. Its thickness is about 0.0000036 inch. This gold leaf is characterized by low content of base metal, a certain porosity, a thickness to permit easy handling and manual application over a skin ulcer so that it closely conforms to virtually all the minute and varied contours of the ulcer and the immediate surrounding area. Substantially thinner gold leaf is difficult to handle because it tends to adhere to the interleaving paper tissues with which it is packaged. Substantially thicker gold leaf does not accommodate to the irregular surface of an ulcer and tends to be too occlusive.
In one controlled experiment, six patients with eleven long-standing non-healing skin ulcers from one to two inches in diameter and unresponsive to usual active therapy were treated with the application of four to eight layers of autoclaved gold leaf (23K XX Deep Gold Leaf for Glass, as aforesaid, and obtained from an artist supply store) after the sites were cleansed with ethyl alcohol. The swabbing of the sites with ethyl alcohol apparently resulted in an increase in electrostatic differential so that the leaf was attracted to the surfaces of the ulcers without the need for stroking with a brush. The sterilized leaf was applied over each ulcer and over the contiguous cutaneous surface. The sites were left uncovered: no other dressing or treatment was used for the duration of the study. The gold leaf remained in situ except in the case of one incontinent Woman with a decubitus ulcer of the buttock (the washing away of the gold by urine every nite necessitate daily reapplication), The sites Were observed and the gold leaf was re-applied at two day intervals. The patients were random, constituting all the available patients with non-healing ulcers at the institution in which the study was performed. A compilation of the study is as follows:
TABLE Patient Size and duration Clinical data Response to gold. leaf 0 ulcers (1) RS Wt 83 yrs 2 ulcers, largest one 2 in. Thrombosis with cellulitis, Pus formation markedly rein diam. 1 month pus, maggots, dissecting duced in 24 hrs; lesions duration. border. dry, epithelialization at (2) ML wt 74 yrs 3 ulcers, each one in. in
diam. 3 month duration.
(3) RE wt 85 yrs Ulcer of dors. of large toe.
3 month duration.
(4) AM wt 67 yrs 2 ulcers, one in. in diam.
6 month duration.
(5) FF Wm 57 yrs 2 ulcers, over one in. in
diam. 5 month duration.
(6) FF wt 73 yrs 1% in.
duratlon.
ulcer over 1 wk Dry crust in 4 days; healing complete in 6 days.
Diabetic; left leg ampu- Smaller ulcer healed in 6 tated; ulcers oi rt. heel. days; larger dry but not completely epitheliized in 10 days. Diabetic; rt. leg ampu- Lesion of 2nd toe not tated; ulcers of 2nd and healed but very vascular;
4th left toes. 4th toe healed in 4 days.
Advanced Parkinsonism; Lesions dry; epithelializagerigbiflus ulcer of rt. tion noted in two days.
application of gold leaf to electrodesiccated skin sites resulted in vascular activity and the production of unusual amounts of granulation tissue. This observation suggested the use of gold in ischemic lesions such as decubitus and arteriosclerotic ulcers of the skin, and resulted in rapid healing in ulcers previously unresponsive to other therapy. Beginning healing was evidenced as early as 2 days after the first application of the gold leaf.
Non-healing cutaneous ulcers means those which do not respond to usual active therapy. Usual active therapy means topical applications of antibiotic and proteolytic agents (including aloe vera). Granulation, as used herein, means tissue which includes blood vessels.
Complete healing was noted within four days (see table) in 6 lesions (four patients) and improvement was present in all treated sites. Complete epithelialization (and remnant discoloration) precluded histo-pathologic studies of these healed lesions. The deepest and widest ulcers of the leg of patient 1, previously surrounded by difiuse erythema, and presenting suppuration, maggot infestation and undermined borders have remained almost completely dry with apparent epithelialization of the borders. It is noteworthy that there has been no surrounding erythema and cellulitis since the third day of treatment. The least responsive lesion is one of two diabetic ulcers in patient 5 whose unhealed lesion appears 3 to have formed more granulation tissue but no epithelialization. A punch biopsy study revealed much granulation tissue in the margin of the lesions of patient 1.
Further studies have revealed curative and beneficial effects of the method when used for varicose ulcers, traumatic ulcers (including burn scars), sclerodermic ulcers, irradiation ulcers, decubitus ulcers, trophic ulcers, neurotic exoriations, erythema induratums, indurated lichenified lesions, and gangrene. In virtually all instances, except with non-painful diabetic ulcers, a marked reduction in pain occurred as soon as the gold leaf was applied. This treatment is also effective in prevention of ulceration, i.e., treatment of superficial bedsores. The treatment has not proved effective in the treatment of ulcers caused by sickle-cell anemia. It is not promising for treatment of normal previously non-pathological sites, such as superficial burns, since it is believed that an excessive amount of granulation tissue would result.
While the precise nature of the functions of the process are not known, it is believed that the application of gold leaf on to ulcers results in stimulation of vascular activity and the production of granulation tissue. The porosity of the gold leaf permits some evaporation of the moisture beneath it, it having been observed that if the leaf is covered by an occlusive substance or dressing, there is interference with healing. While, in some instances, the gold leaf can be applied Without initially swabbing of the site, it is preferred that the site first be swabbed with ethyl alcohol, not only to cleanse it, but also to establish the electrostatic differential which causes the leaf to adhere closely to the irregular surface of the ulcer with little or no further manipulation required.
In its broader aspect, the invention embraces a therapeutic device, i.e., sterile porous gold leaf of about 0.0000036 inch thickness for stimulating vascular activity and the production of granulation tissue at the site of a lesion of the skin. The invention is not limited to the specific method or article, but is intended to cover all substitutions, modifications, and equivalents within the scope of the following claim.
I claim:
1. The method of stimulating epithelialization in a cutaneous region at and proximate to an avascular ulcer other than a cutaneous region fed by blood containing sickle cells by means of sterile porous gold leaf applied thereto which comprises, first establishing an electrostatic differential between the ulcer and the gold leaf by applying ethyl alcohol to the site of the ulcer, and then applying said sterile porous golf leaf in intimate engagement over said ulcer and the cutaneous surface immediately contiguous thereto, and maintaining said gold leaf so applied until epithelialization is stimulated and develops at the ulcer.
References Cited UNITED STATES PATENTS 3,326,213 6/1967 Gallagher 128156 ADELE M. EAGER, Primary Examiner.
US. Cl. X.R. 128156
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51016165A | 1965-11-24 | 1965-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3420233A true US3420233A (en) | 1969-01-07 |
Family
ID=24029609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US510161A Expired - Lifetime US3420233A (en) | 1965-11-24 | 1965-11-24 | Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3420233A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2443836A1 (en) * | 1978-12-13 | 1980-07-11 | Perma | Skin beauty treatment with substance active at body temp. - which is applied and covered with reflective aluminium foil |
| US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
| US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
| US7005556B1 (en) | 1995-09-05 | 2006-02-28 | Argentum Medical | Multilayer wound dressing |
| US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
| US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
| US8449514B2 (en) | 1997-09-22 | 2013-05-28 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3326213A (en) * | 1964-07-09 | 1967-06-20 | John P Gallagher | Therapeutic dressing material and method of using the same |
-
1965
- 1965-11-24 US US510161A patent/US3420233A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3326213A (en) * | 1964-07-09 | 1967-06-20 | John P Gallagher | Therapeutic dressing material and method of using the same |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2443836A1 (en) * | 1978-12-13 | 1980-07-11 | Perma | Skin beauty treatment with substance active at body temp. - which is applied and covered with reflective aluminium foil |
| US8118791B2 (en) | 1995-09-05 | 2012-02-21 | Argentum Medical, Llc | Medical device |
| US20080114279A1 (en) * | 1995-09-05 | 2008-05-15 | Argentum Medical, Llc | Multilayer laminate wound dressing |
| US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
| US7005556B1 (en) | 1995-09-05 | 2006-02-28 | Argentum Medical | Multilayer wound dressing |
| US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
| US8293964B2 (en) | 1995-09-05 | 2012-10-23 | Argentum Medical, Llc | Multilayer laminate wound dressing |
| US8283513B2 (en) | 1995-09-05 | 2012-10-09 | Argentum Medical, Llc | Multilayer wound dressing |
| US20070179522A1 (en) * | 1995-09-05 | 2007-08-02 | Argentum Medical, Llc | Multilayer wound dressing |
| US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
| US7291762B2 (en) | 1997-09-22 | 2007-11-06 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
| US7989674B2 (en) | 1997-09-22 | 2011-08-02 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
| EP2316524A1 (en) | 1997-09-22 | 2011-05-04 | Argentum International, LLC | Multilayer conductive appliance having wound healing and analgesic properties |
| US20080033506A1 (en) * | 1997-09-22 | 2008-02-07 | Argentum International, Llc | Multilayer Conductive Appliance Having Wound Healing and Analgesic Properties |
| US8093444B2 (en) | 1997-09-22 | 2012-01-10 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
| US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
| US7230153B2 (en) | 1997-09-22 | 2007-06-12 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
| US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
| US8449514B2 (en) | 1997-09-22 | 2013-05-28 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
| US8455710B2 (en) | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
| US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Modaghegh et al. | Use of phenytoin in healing of war and non‐war wounds: A pilot study of 25 cases | |
| Ortonne | A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers | |
| US4330527A (en) | Wound treatment agent | |
| Schoenfeld et al. | Calcium deposition in the skin: a report of four cases following electroencephalography | |
| SGAPICCHIO et al. | Comparative effects of silver nitrate and sulfamylon acetate on epidermal regeneration | |
| Brunsting et al. | Cutaneous ulcers treated by the sulphydryl containing amino-acid cysteine | |
| CN112933214A (en) | Composition for promoting wound healing | |
| BETTMAN | A simpler technic for promoting epithelization and protecting skin grafts | |
| Lynch et al. | The promotion of wound healing following chemosurgery (Mohs' technique) by dressings with a lotion of benzoyl peroxide | |
| Glickman et al. | Psoriatic angiogenic factor: evidence for its existence | |
| RU2816783C1 (en) | Method of treating an ingrown nail | |
| RU2198702C1 (en) | Method for preparing trophic ulcers to autodermatoplastic repair | |
| MITCHINER | The Treatment of Burns and Scalds, with especial reference tq the use of Tannic Acid. | |
| MONTGOMERY et al. | Mosaic Type of Plantar Wart: Its Characteristics and Treatment | |
| Seldon et al. | STIMULATION OF WOUND HEALING: A NEW USE FOE POWDERED BLOOD CELLS | |
| RU2150957C1 (en) | Method of treatment of scar-modified tissue | |
| Feit | The use of thorium X in treatment of pilonidal cyst: a preliminary report | |
| DUEMLING | CUTANEOUS DISEASES IN THE SOUTH PACIFIC: OBSERVATIONS AMONG MILITARY FORCES | |
| BERESTON et al. | Treatment of undermining acne lesions by exteriorization | |
| Blomgren et al. | A Clinical Study of Trypure® or Varidase® on Minor Burns | |
| LEVAN | IMPROVED DERMAL ABRASION POSTOPERATIVE DRESSING | |
| Isaak | Treatment of cutaneous diseases with radon ointment and radium pads: a preliminary report | |
| Gallant | VI. Report upon the use of a mixture of castor oil and balsam of Peru as a surgical dressing | |
| Feinman | Tropical Ulcer | |
| Ross | Diprosone ointment in psoriasis-a double-blind trial |